Generic pharmaceuticals company Actavis Group has appointed former Ratiopharm leader Claudio Albrecht, PhD, as its new CEO.
Albrecht started his career with Sandoz in 1987 where he served as a managing director in the Netherlands, Germany and the U.S., according to Reykjavik, Iceland-based company. In 2000, he joined generics company Ratiopharm as CEO. In 2008, Albrecht established Cometh, a consultancy that advises pharmaceutical companies, including Actavis, on growth strategies.
Sigurdur Oli Olafsson is standing down as Actavis' CEO, following seven years in senior management roles.